Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Trends Pharmacol Sci ; 44(9): 622-634, 2023 09.
Article in English | MEDLINE | ID: mdl-37468402

ABSTRACT

Neutrophil extracellular traps (NETs) are complex structures released by activated neutrophils during inflammatory responses. Due to their unique potential for causing tissue damage and modulating immune responses, there is increasing interest in studying these structures as potential targets for the treatment of infectious diseases, autoimmune diseases, and cancer. However, therapeutic targeting of NETs might trigger deleterious effects that may limit treatment efficacy. NET disruption may increase the microbial load in infection; in autoimmunity, NET targeting might impair peripheral tolerance, but it might reduce adaptive immune responses in cancer. In this review, we explore the therapeutic and deleterious effects of NET-targeted therapy while shedding light on novel strategies to overcome treatment-related limitations and enhance treatment efficacy.


Subject(s)
Autoimmune Diseases , Extracellular Traps , Humans , Extracellular Traps/physiology , Neutrophils , Autoimmune Diseases/drug therapy , Treatment Outcome
2.
Clin Rheumatol ; 38(9): 2433-2441, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31004305

ABSTRACT

OBJECTIVE: To evaluate the oral health-related quality of life (OHRQoL) of individuals with rheumatoid arthritis (RA) in comparison with individuals with no RA. METHOD: A cross-sectional study was carried out with 112 individuals distributed into two groups. Group 1 (G1) consisted of 42 RA individuals and group 2 (G2) consisted of 70 individuals without RA. Participants' OHRQoL was assessed by means of the long form of the Oral Health Impact Profile (OHIP). The OHIP has 49 questions distributed across seven domains: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability, and handicap. The overall score ranges between 0 and 196. A higher score denotes a greater negative impact on OHRQoL. All participants underwent oral examination for the evaluation of clinical variables. Sociodemographic and oral behavior variables were also collected. Data analysis included descriptive statistics, Mann-Whitney test, and regression analysis. RESULTS: Individuals in G1 presented higher OHIP overall score (p = 0.006) than G2 individuals. G1 individuals also presented higher scores in the functional limitation (p = 0.003) and the physical disability (p = 0.005) domains than G2 individuals. Individuals with RA (p = 0.044), individuals who brushed their teeth less often (p = 0.019), and those with a higher number of decayed, missing, and filled teeth (DMFT) (p = 0.038) presented a significantly higher OHIP-49 overall score (more negative perception of their OHRQoL) than individuals without RA, individuals who brushed their teeth more often, and those with a lower DMFT. CONCLUSION: RA individuals had a more negative perception of their OHRQoL compared with individuals with no RA.


Subject(s)
Arthritis, Rheumatoid/complications , Oral Health , Periodontitis/complications , Quality of Life , Adult , Case-Control Studies , Female , Health Surveys , Humans , Male , Middle Aged
3.
Arthritis Res Ther ; 20(1): 119, 2018 06 08.
Article in English | MEDLINE | ID: mdl-29884199

ABSTRACT

BACKGROUND: Epidemiologic studies have highlighted the association of environmental factors with the development and progression of autoimmune and chronic inflammatory diseases. Among the environmental factors, smoking has been associated with increased susceptibility and poor prognosis in rheumatoid arthritis (RA). However, the immune and molecular mechanism of smoking-induced arthritis aggravation remains unclear. The transcription factor aryl hydrocarbon receptor (AHR) regulates the generation of Th17 cells, CD4 T cells linked the development of autoimmune diseases. AHR is activated by organic compounds including polycyclic aromatic hydrocarbons (PAHs), which are environmental pollutants that are also present in cigarette smoke. In this study, we investigated the role of AHR activation in the aggravation of experiment arthritis induced by exposure to cigarette smoke. METHODS: Mice were exposed to cigarette smoke during the developmental phase of antigen-induced arthritis and collagen-induced arthritis to evaluate the effects of smoking on disease development. Aggravation of articular inflammation was assessed by measuring neutrophil migration to the joints, increase in articular hyperalgesia and changes in the frequencies of Th17 cells. In vitro studies were performed to evaluate the direct effects of cigarette smoke and PAH on Th17 differentiation. We also used mice genetically deficient for AHR (Ahr KO) and IL-17Ra (Il17ra KO) to determine the in vivo mechanism of smoking-induced arthritis aggravation. RESULTS: We found that smoking induces arthritis aggravation and increase in the frequencies of Th17 cells. The absence of IL-17 signaling (Il17ra KO) conferred protection to smoking-induced arthritis aggravation. Moreover, in vitro experiments showed that cigarette smoke can directly increase Th17 differentiation of T cells by inducing AHR activation. Indeed, Ahr KO mice were protected from cigarette smoke-induced arthritis aggravation and did not display increase in TH17 frequencies, suggesting that AHR activation is an important mechanism for cigarette smoke effects on arthritis. Finally, we demonstrate that PAHs are also able to induce arthritis aggravation. CONCLUSIONS: Our data demonstrate that the disease-exacerbating effects of cigarette smoking are AHR dependent and environmental pollutants with AHR agonist activity can induce arthritis aggravation by directly enhancing Th17 cell development.


Subject(s)
Arthritis, Experimental/metabolism , Receptors, Aryl Hydrocarbon/metabolism , Smoke/adverse effects , Th17 Cells/metabolism , Animals , Arthritis, Experimental/etiology , Arthritis, Experimental/genetics , Azo Compounds/pharmacology , Male , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Knockout , Pyrazoles/pharmacology , Receptors, Aryl Hydrocarbon/antagonists & inhibitors , Receptors, Aryl Hydrocarbon/genetics , Receptors, Interleukin-17/genetics , Receptors, Interleukin-17/metabolism , Nicotiana/chemistry
4.
Bioelectron Med (Lond) ; 1(2): 151-165, 2018 May.
Article in English | MEDLINE | ID: mdl-30740246

ABSTRACT

Neuronal stimulation is an emerging field in modern medicine to control organ function and reestablish physiological homeostasis during illness. The nervous system innervates most of the peripheral organs and provides a fine tune to control the immune system. Most of these studies have focused on vagus nerve stimulation and the physiological, cellular and molecular mechanisms regulating the immune system. Here, we review the new results revealing afferent vagal signaling pathways, immunomodulatory brain structures, spinal cord-dependent circuits, neural and non-neural cholinergic/catecholaminergic signals and their respective receptors contributing to neuromodulation of inflammation in rheumatoid arthritis. These new neuromodulatory networks and structures will allow the design of innovative bioelectronic or pharmacological approaches for safer and low-cost treatment of arthritis and related inflammatory disorders.

5.
Dig Dis Sci ; 62(1): 93-104, 2017 01.
Article in English | MEDLINE | ID: mdl-27864656

ABSTRACT

AIM: The objective was to evaluate the effects of nitric oxide (NO) and hydrogen sulfide (H2S) donors and possible interactions between these two systems in modulating gastric function. METHODS: Mice received saline, sodium nitroprusside (SNP), or sodium hydrosulfite (NaHS), and after 1 h, the animals were killed for immunofluorescence analysis of CSE or eNOS expressions, respectively. Other groups received saline, SNP, NaHS, Lawesson's reagent (H2S donor), PAG + SNP, L-NAME, L-NAME + NaHS, or L-NAME + Lawesson's reagent. Then, the gastric secretions (mucous and acid), gastric blood flow, gastric defense against ethanol, and gastric motility (gastric emptying and gastric contractility) were evaluated. RESULTS: SNP and NaHS increased the expression of CSE or eNOS, respectively. SNP or Lawesson's reagent did not alter gastric acid secretion but increased mucus production, and these effects reverted with PAG and L-NAME treatment, respectively. SNP or NaHS increased gastric blood flow and protected the gastric mucosa against ethanol injury, and these effects reverted with PAG and L-NAME treatments, respectively. SNP delayed gastric emptying when compared with saline, and PAG partially reversed this effect. NaHS accelerate gastric emptying, and L-NAME partially reversed this effect. SNP and NaHS alone induced gastric fundus and pylorus relaxation. However, pretreatment with PAG or L-NAME reversed these relaxant effects only in the pylorus but not in the gastric fundus. CONCLUSION: NO and H2S interact in gastric physiological functions, and this "cross-talk" is important in the control of mucus secretion, gastric blood flow, gastric mucosal defense, and gastric motility, but not in the control of basal gastric acid secretion.


Subject(s)
Cystathionine gamma-Lyase/drug effects , Gastric Emptying/drug effects , Nitric Oxide Donors/pharmacology , Nitric Oxide Synthase Type III/drug effects , Nitroprusside/pharmacology , Stomach/drug effects , Sulfides/pharmacology , Alkynes/pharmacology , Animals , Central Nervous System Depressants/pharmacology , Cystathionine gamma-Lyase/antagonists & inhibitors , Cystathionine gamma-Lyase/metabolism , Drug Interactions , Enzyme Inhibitors/pharmacology , Ethanol/pharmacology , Fluorescent Antibody Technique , Gastric Acid/metabolism , Gastric Fundus/drug effects , Gastric Mucosa/drug effects , Gastric Mucosa/metabolism , Glutathione/drug effects , Glutathione/metabolism , Glycine/analogs & derivatives , Glycine/pharmacology , Laser-Doppler Flowmetry , Male , Malondialdehyde/metabolism , Mice , Mucus/drug effects , Mucus/metabolism , Muscle Contraction/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Nitric Oxide Synthase Type III/antagonists & inhibitors , Nitric Oxide Synthase Type III/metabolism , Pylorus/drug effects , Rats , Rats, Wistar , Regional Blood Flow , Stomach/blood supply
6.
Inflamm Res ; 64(10): 781-7, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26245235

ABSTRACT

OBJECTIVE: We investigated the anti-inflammatory activity of strontium ranelate (SR) in arthritis models. MATERIALS AND METHODS: Rats received 1 mg zymosan (Zy) or saline intra-articularly. Other groups were subjected to anterior cruciate ligament transection in the right knee, as an osteoarthritis (OA) model, or a sham procedure. Joint pain was assessed using the articular incapacitation and paw-pressure tests. Cell influx and cytokines were measured in joint exudates. TREATMENT: Groups received either SR (30-300 mg/kg per os) or saline. RESULTS: SR dose-dependently and significantly inhibited joint pain in both Zy and OA models, while not altering cell influx. Naloxone administration significantly reversed SR analgesia. SR significantly reduced levels of Interleukin-1ß and tumor necrosis factor-α in Zy arthritis, whereas those of cytokine-induced neutrophil chemoattractant (CINC)-1 were not altered. CONCLUSIONS: SR provides analgesia in arthritis that is associated to inhibition of the release of inflammatory cytokines into inflamed joints. This effect is abrogated by administration of the opioid antagonist naloxone.


Subject(s)
Analgesics, Non-Narcotic/therapeutic use , Cytokines/metabolism , Osteoarthritis/drug therapy , Osteoarthritis/metabolism , Receptors, Opioid/drug effects , Thiophenes/therapeutic use , Animals , Arthralgia/drug therapy , Chemokine CXCL1/metabolism , Dose-Response Relationship, Drug , Injections, Intra-Articular , Interleukin-1beta/metabolism , Joints/pathology , Naloxone/therapeutic use , Narcotic Antagonists/pharmacology , Osteoarthritis/pathology , Pain Measurement , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/metabolism
7.
Inflamm Res ; 63(12): 969-77, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25286904

ABSTRACT

OBJECTIVE AND DESIGN: The aim of this study was to investigate the possible involvement of the NO/cGMP/PKG/KATP+ pathway, cannabinoids and opioids in remote antinociception associated with 2,4,6-trinitrobenzene sulph onic acid (TNBS)-induced colitis. METHODS: TNBS-induced colitis was induced by intracolonic administration of 20 mg of TNBS in 50% ethanol. After induction, carrageenan (500 µg/paw) or prostaglandin (PG) E2 (100 ng/paw) was injected in the rat's plantar surface and hypersensitivity was evaluated by the electronic von Frey test. Rats were pre-treated with L-Noarg one hour before carrageenan injection. L-Arginine was given 10 min before L-Noarg injections. ODQ, KT 5823, glibenclamide (Glib), naloxone and AM 251 or AM 630 were administered 30 min prior to carrageenan or PGE2 treatments. RESULTS: Colitis induction by TNBS reduced PGE2 or carrageenan-induced hypersensitivity. Antinociception produced by TNBS-induced colitis was reversed significantly (P<0.05) by L-Noarg, ODQ, KT 5823, glibenclamide, naloxone, AM251 and AM630 treatments. CONCLUSIONS: TNBS-induced colitis causes antinociception in the rat paw. This disorder appears to be mediated by activation of the NO/cGMP/PKG/KATP pathway, endocannabinoids and endogenous opioids. This information may contribute to a better understanding of peripheral neurological dysfunctions occurring in Crohn's disease.


Subject(s)
Colitis/metabolism , Cyclic GMP-Dependent Protein Kinases/metabolism , Cyclic GMP/metabolism , KATP Channels/metabolism , Neurons/drug effects , Nitric Oxide/metabolism , Nociception/drug effects , Analgesics, Opioid/metabolism , Animals , Arginine/chemistry , Cannabinoids/metabolism , Carrageenan/chemistry , Colon/drug effects , Dinoprostone/chemistry , Male , Rats , Rats, Wistar , Trinitrobenzenesulfonic Acid/chemistry
8.
Naunyn Schmiedebergs Arch Pharmacol ; 380(5): 407-14, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19705102

ABSTRACT

The aim of the present study was to evaluate the potential antinociceptive and toxicity of Canavalia boliviana lectin (CboL) using different methods in mice. The role of carbohydrate-binding sites was also investigated. CboL given to mice daily for 14 days at doses of 5 mg/kg did not cause any observable toxicity. CboL (1, 5, and 10 mg/kg) administered to mice intravenously inhibited abdominal constrictions induced by acetic acid and the two phases of the formalin test. In the hot plate and tail immersion tests, the same treatment of CboL induced significant increase in the latency period. In the hot plate test, the effect of CboL (5 mg/kg) was reversed by naloxone (1 mg/kg), indicating the involvement of the opioid system. In the open-field and rota-rod tests, the CboL treatment did not alter animals' motor function. These results show that CboL presents antinociceptive effects of both central and peripheral origin, involving the participation of the opioid system via lectin domain.


Subject(s)
Analgesics/pharmacology , Canavalia/chemistry , Pain/drug therapy , Plant Lectins/pharmacology , Analgesics/administration & dosage , Analgesics/toxicity , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Male , Mice , Pain Measurement , Plant Lectins/administration & dosage , Plant Lectins/toxicity , Seeds
9.
Obes Surg ; 19(7): 867-72, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19434466

ABSTRACT

BACKGROUND: Obesity has become a global epidemic and bariatric surgery is one of the therapeutic tools to deal with it. Postoperative complications can occur, such as staple line dehiscence and anastomotic leaks, leading to increased patient mortality. The diagnosis of these complications is frequently difficult. The objective of the present study was to determine whether peritoneal and systemic cytokines could early detect those complications. METHODS: All patients who underwent open Roux-en-Y gastric bypass from February 2007 to August 2008 were prospectively evaluated. Blood and peritoneal effluent from the drain were collected for the determination of cytokine levels. We also evaluated the clinical signs and the leukograms of the patients. RESULTS: A total of 107 obese patients were studied. Ninety patients had no complications; 17 had at least one infectious complication which include five cases of staple line dehiscence. Until the third postoperative day, the vital signs and the leukogram did not predict the onset of infectious complications, but the cytokines (interleukin-1beta and interleukin-6) were early markers of these complications. CONCLUSION: Cytokines are good predictors of poor postoperative evolution in bariatric surgery since peritoneal cytokines diagnose better these infectious complications even before changes in blood count and before the occurrence of clinical manifestations.


Subject(s)
Bariatric Surgery/adverse effects , Postoperative Complications/diagnosis , Surgical Wound Dehiscence/etiology , Surgical Wound Infection/diagnosis , Adult , Biomarkers/blood , Female , Humans , Interleukin-1/blood , Interleukin-6/blood , Male , Peritonitis/immunology , Postoperative Complications/prevention & control , Surgical Wound Infection/prevention & control , Time Factors , Treatment Outcome , Tumor Necrosis Factor-alpha/blood
10.
Biochem Pharmacol ; 77(5): 867-77, 2009 Mar 01.
Article in English | MEDLINE | ID: mdl-19073148

ABSTRACT

In the present study, the participation of the Na(V)1.8 sodium channel was investigated in the development of the peripheral pro-nociceptive state induced by daily intraplantar injections of PGE(2) in rats and its regulation in vivo by protein kinase A (PKA) and protein kinase C epsilon (PKCvarepsilon) as well. In the prostaglandin E(2) (PGE(2))-induced persistent hypernociception, the Na(V)1.8 mRNA in the dorsal root ganglia (DRG) was up-regulated. The local treatment with dipyrone abolished this persistent hypernociception but did not alter the Na(V)1.8 mRNA level in the DRG. Daily intrathecal administrations of antisense Na(V)1.8 decreased the Na(V)1.8 mRNA in the DRG and reduced ongoing persistent hypernociception. Once the persistent hypernociception had been abolished by dipyrone, but not by Na(V)1.8 antisense treatment, a small dose of PGE(2) restored the hypernociceptive plateau. These data show that, after a period of recurring inflammatory stimuli, an intense and prolonged nociceptive response is elicited by a minimum inflammatory stimulus and that this pro-nociceptive state depends on Na(V)1.8 mRNA up-regulation in the DRG. In addition, during the persistent hypernociceptive state, the PKA and PKCvarepsilon expression and activity in the DRG are up-regulated and the administration of the PKA and PKCvarepsilon inhibitors reduce the hypernociception as well as the Na(V)1.8 mRNA level. In the present study, we demonstrated that the functional regulation of the Na(V)1.8 mRNA by PKA and PKCvarepsilon in the primary sensory neuron is important for the development of the peripheral pro-nociceptive state induced by repetitive inflammatory stimuli and for the maintenance of the behavioral persistent hypernociception.


Subject(s)
Cyclic AMP-Dependent Protein Kinases/metabolism , Inflammation/physiopathology , Nerve Tissue Proteins/physiology , Pain/physiopathology , Protein Kinase C-epsilon/metabolism , Sodium Channels/physiology , Animals , Base Sequence , DNA Primers , Dinoprostone/administration & dosage , Enzyme Activation , Inflammation/chemically induced , Male , NAV1.8 Voltage-Gated Sodium Channel , Pain/enzymology , Polymerase Chain Reaction , Rats , Rats, Wistar
11.
Parasitol Res ; 102(4): 801-3, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18094999

ABSTRACT

Leishmania amazonensis infection leads to progressive diseases in a majority of inbred strains of mice. Glutathione (GSH) participates in a large number of cellular phenomena and seems to be essential for several immune functions, including host defense during leishmaniasis. In this study, we evaluated the effects of N-acetyl-L: -cysteine (NAC), as GSH supplement, on the course of L. amazonensis infection in susceptible BALB/c mice. The treatment with NAC (200 mg/kg daily) was effective in raising GSH levels in both lymph node and spleen cells. Although this treatment did not change the footpad swelling development in L. amazonensis-infected mice, it caused a significant decrease in the number of parasites recovered from the footpad lesion and draining popliteal lymph node. Our data suggest that intracellular Leishmania killing in vivo was improved by the augment of GSH levels through NAC administration.


Subject(s)
Acetylcysteine/administration & dosage , Glutathione/metabolism , Leishmania/drug effects , Leishmaniasis, Cutaneous/drug therapy , Leishmaniasis, Cutaneous/parasitology , Animals , Female , Foot/parasitology , Foot/pathology , Leishmania/classification , Leishmania/isolation & purification , Leishmania/pathogenicity , Leishmaniasis, Cutaneous/pathology , Lymph Nodes/metabolism , Lymph Nodes/parasitology , Mice , Mice, Inbred BALB C , Spleen/metabolism , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...